Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 337 to 343 of 343 entries
Sorted by: Best Match Show Resources per page
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.

Leukemia & lymphoma

Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T.
PMID: 34405767
Leuk Lymphoma. 2021 Dec;62(14):3384-3393. doi: 10.1080/10428194.2021.1966782. Epub 2021 Aug 18.

This national Israeli multicenter retrospective study aimed to characterize the clinical course of COVID-19 infection among patients with hematological malignancies, with special emphasis on treatment efficacy and outcome. Clinical and laboratory data from haemato-oncological patients diagnosed with COVID-19 from...

Cite
Levy I, Lavi A, Zimran E, et al. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma. 2021;62(14):3384-3393doi: 10.1080/10428194.2021.1966782.
Levy, I., Lavi, A., Zimran, E., Grisariu, S., Aumann, S., Itchaki, G., Berger, T., Raanani, P., Harel, R., Aviv, A., Lavi, N., Zuckerman, T., Shvidel, L., Jarchowsky, O., Ellis, M., Herzog Tzarfati, K., Koren-Michowitz, M., Sherf, Y., Levi, I., Sofer, O., Shpilberg, O., Dally, N., Suriu, C., Braester, A., Ben Barouch, S., Leiba, M., Goldstein, D., Sarid, N., Yeganeh, S., Halloun, J., Mittelman, M., & Tadmor, T. (2021). COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leukemia & lymphoma, 62(14), 3384-3393. https://doi.org/10.1080/10428194.2021.1966782
Levy, Ilana, et al. "COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome." Leukemia & lymphoma vol. 62,14 (2021): 3384-3393. doi: https://doi.org/10.1080/10428194.2021.1966782
Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma. 2021 Dec;62(14):3384-3393. doi: 10.1080/10428194.2021.1966782. Epub 2021 Aug 18. PMID: 34405767.
Copy Download .nbib Format: NLM
An ex vivo model of human corneal rim perfusion organ culture.

Experimental eye research

Peng M, Margetts TJ, Sugali CK, Rayana NP, Dai J, Sharma TP, Raghunathan VK, Mao W.
PMID: 34896309
Exp Eye Res. 2021 Dec 09;214:108891. doi: 10.1016/j.exer.2021.108891. Epub 2021 Dec 09.

The human anterior segment perfusion culture model is a valuable tool for studying the trabecular meshwork (TM) and aqueous humor outflow in glaucoma. The traditional model relies on whole eye globes resulting in high cost and limited availability. Here,...

Cite
Peng M, Margetts TJ, Sugali CK, et al. An ex vivo model of human corneal rim perfusion organ culture. Exp Eye Res. 2021;214:108891doi: 10.1016/j.exer.2021.108891.
Peng, M., Margetts, T. J., Sugali, C. K., Rayana, N. P., Dai, J., Sharma, T. P., Raghunathan, V. K., & Mao, W. (2021). An ex vivo model of human corneal rim perfusion organ culture. Experimental eye research, 214108891. https://doi.org/10.1016/j.exer.2021.108891
Peng, Michael, et al. "An ex vivo model of human corneal rim perfusion organ culture." Experimental eye research vol. 214 (2021): 108891. doi: https://doi.org/10.1016/j.exer.2021.108891
Peng M, Margetts TJ, Sugali CK, Rayana NP, Dai J, Sharma TP, Raghunathan VK, Mao W. An ex vivo model of human corneal rim perfusion organ culture. Exp Eye Res. 2021 Dec 09;214:108891. doi: 10.1016/j.exer.2021.108891. Epub 2021 Dec 09. PMID: 34896309.
Copy Download .nbib Format: NLM
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.

Nature medicine

Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J.
PMID: 34697502
Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25.

Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days...

Cite
Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144-2153doi: 10.1038/s41591-021-01556-7.
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., Hunt, D., Mei, X. W., Dixon, S., Zaccardi, F., Khunti, K., Watkinson, P., Coupland, C. A. C., Doidge, J., Harrison, D. A., Ravanan, R., Sheikh, A., Robertson, C., & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://doi.org/10.1038/s41591-021-01556-7
Patone, Martina, et al. "Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection." Nature medicine vol. 27,12 (2021): 2144-2153. doi: https://doi.org/10.1038/s41591-021-01556-7
Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25. PMID: 34697502; PMCID: PMC8629105.
Copy Download .nbib Format: NLM
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.

Nature medicine

Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J.
PMID: 34697502
Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25.

Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days...

Cite
Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144-2153doi: 10.1038/s41591-021-01556-7.
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., Hunt, D., Mei, X. W., Dixon, S., Zaccardi, F., Khunti, K., Watkinson, P., Coupland, C. A. C., Doidge, J., Harrison, D. A., Ravanan, R., Sheikh, A., Robertson, C., & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://doi.org/10.1038/s41591-021-01556-7
Patone, Martina, et al. "Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection." Nature medicine vol. 27,12 (2021): 2144-2153. doi: https://doi.org/10.1038/s41591-021-01556-7
Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25. PMID: 34697502; PMCID: PMC8629105.
Copy Download .nbib Format: NLM
Quantifying molecular aggregation by super resolution microscopy within an excitatory synapse from mouse hippocampal neurons.

STAR protocols

Kedia S, Ramanan N, Nair D.
PMID: 33937876
STAR Protoc. 2021 Apr 14;2(2):100470. doi: 10.1016/j.xpro.2021.100470. eCollection 2021 Jun 18.

Super-resolution microscopy (SRM) has been widely adopted to probe molecular distribution at excitatory synapses. We present an SRM paradigm to evaluate the nanoscale organization heterogeneity between neuronal subcompartments. Using mouse hippocampal neurons, we describe the identification of the morphological...

Cite
Kedia S, Ramanan N, Nair D. Quantifying molecular aggregation by super resolution microscopy within an excitatory synapse from mouse hippocampal neurons. STAR Protoc. 2021;2(2):100470doi: 10.1016/j.xpro.2021.100470.
Kedia, S., Ramanan, N., & Nair, D. (2021). Quantifying molecular aggregation by super resolution microscopy within an excitatory synapse from mouse hippocampal neurons. STAR protocols, 2(2), 100470. https://doi.org/10.1016/j.xpro.2021.100470
Kedia, Shekhar, et al. "Quantifying molecular aggregation by super resolution microscopy within an excitatory synapse from mouse hippocampal neurons." STAR protocols vol. 2,2 (2021): 100470. doi: https://doi.org/10.1016/j.xpro.2021.100470
Kedia S, Ramanan N, Nair D. Quantifying molecular aggregation by super resolution microscopy within an excitatory synapse from mouse hippocampal neurons. STAR Protoc. 2021 Apr 14;2(2):100470. doi: 10.1016/j.xpro.2021.100470. eCollection 2021 Jun 18. PMID: 33937876; PMCID: PMC8076707.
Copy Download .nbib Format: NLM
Clinical profiles and risk factors for early and medium-term mortality following heart transplantation in a pediatric population: A single-center experience.

Annals of pediatric cardiology

Balakrishnan KR, Rao KGS, Subramaniam GK, Tanguturu MK, Arvind A, Ramanan V, Dhushyanthan J, Ramasubramanian K, Kumaran KS, Sellamuthu G, Rajam M, Mettur S, Gnansekharan P, Ratnagiri R.
PMID: 33679060
Ann Pediatr Cardiol. 2021 Jan-Mar;14(1):42-52. doi: 10.4103/apc.APC_129_20. Epub 2021 Jan 16.

AIMS AND OBJECTIVES: There is a paucity of data regarding the outcomes of Heart transplantation in children from the Indian subcontinent. The data of patients under the age of 18 undergoing an isolated heart transplantation was analyzed for patient...

Cite
Balakrishnan KR, Rao KGS, Subramaniam GK, et al. Clinical profiles and risk factors for early and medium-term mortality following heart transplantation in a pediatric population: A single-center experience. Ann Pediatr Cardiol. 2021;14(1):42-52doi: 10.4103/apc.APC_129_20.
Balakrishnan, K. R., Rao, K. G. S., Subramaniam, G. K., Tanguturu, M. K., Arvind, A., Ramanan, V., Dhushyanthan, J., Ramasubramanian, K., Kumaran, K. S., Sellamuthu, G., Rajam, M., Mettur, S., Gnansekharan, P., & Ratnagiri, R. (2021). Clinical profiles and risk factors for early and medium-term mortality following heart transplantation in a pediatric population: A single-center experience. Annals of pediatric cardiology, 14(1), 42-52. https://doi.org/10.4103/apc.APC_129_20
Balakrishnan, Komarakshi R, et al. "Clinical profiles and risk factors for early and medium-term mortality following heart transplantation in a pediatric population: A single-center experience." Annals of pediatric cardiology vol. 14,1 (2021): 42-52. doi: https://doi.org/10.4103/apc.APC_129_20
Balakrishnan KR, Rao KGS, Subramaniam GK, Tanguturu MK, Arvind A, Ramanan V, Dhushyanthan J, Ramasubramanian K, Kumaran KS, Sellamuthu G, Rajam M, Mettur S, Gnansekharan P, Ratnagiri R. Clinical profiles and risk factors for early and medium-term mortality following heart transplantation in a pediatric population: A single-center experience. Ann Pediatr Cardiol. 2021 Jan-Mar;14(1):42-52. doi: 10.4103/apc.APC_129_20. Epub 2021 Jan 16. PMID: 33679060; PMCID: PMC7918032.
Copy Download .nbib Format: NLM
Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors.

Cancers

Telerman A, Granot G, Leibovitch C, Yarchovsky-Dolberg O, Shacham-Abulafia A, Partouche S, Yeshurun M, Ellis MH, Raanani P, Wolach O.
PMID: 35008283
Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010119.

Cardiovascular complications are increasingly reported with the use of certain tyrosine kinase inhibitors (TKIs) to treat chronic myeloid leukemia (CML). We studied neutrophil extracellular trap (NET) formation in CML and evaluated the effect of TKIs on NET formation. Neutrophils...

Cite
Telerman A, Granot G, Leibovitch C, et al. Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010119.
Telerman, A., Granot, G., Leibovitch, C., Yarchovsky-Dolberg, O., Shacham-Abulafia, A., Partouche, S., Yeshurun, M., Ellis, M. H., Raanani, P., & Wolach, O. (2021). Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors. Cancers, 14(1), . https://doi.org/10.3390/cancers14010119
Telerman, Alona, et al. "Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010119
Telerman A, Granot G, Leibovitch C, Yarchovsky-Dolberg O, Shacham-Abulafia A, Partouche S, Yeshurun M, Ellis MH, Raanani P, Wolach O. Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors. Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010119. PMID: 35008283.
Copy Download .nbib Format: NLM
Showing 337 to 343 of 343 entries